STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

EVGN EVOGENE LTD StockScouter® Report

4

StockScouter® Score

EVOGENE LTD, a micro cap value company in the healthcare sector, is expected to underperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
  • Shares are under accumulation by financial institutions. Marginally positive for a small company like EVGN

 

Concerns

  • The multi-period measure of relative price change and consistency is well below average. Negative
  • Moving average analysis for EVGN suggests weak price movement over the medium term. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, value stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 80% done.
Progress: 20% done.
Low
High

Core Model Grades

C
C
D
F

Previous Ratings

6
7
6